CNR Institutional Research Information System

ZUCCA, FABIO ANDREA

ZUCCA, FABIO ANDREA  

Istituto di Tecnologie Biomediche - ITB  

Mostra records
Risultati 1 - 20 di 111 (tempo di esecuzione: 0.023 secondi).
Titolo Data di pubblicazione Autore(i) File
Modeling Midbrain and Brainstem Neuromelanins to Characterize Metal Binding and Associated MRI Contrast in Parkinson's and Alzheimer's Diseases 1-gen-2025 Wallstein, N.; Capucciati, A.; Pöppl, A.; Schnohr, C. S.; Sturini, M.; Pampel, A.; Jäger, C.; Zecca, L.; Zucca, F. A.; Monzani, E.; Casella, L.; Möller, H. E.
α-Synuclein and Dopamine Metabolites DOPAL and DOPAC: A Pathway to New Synthetic Neuromelanin Models 1-gen-2025 Capucciati, A.; Sturini, M.; Nicolis, S.; Zucca, F. A.; Bisaglia, M.; Favetta, G.; Bortolus, M.; Zecca, L.; Pezzoli, G.; Casella, L.; Monzani, E.
DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's disease 1-gen-2023 Cai, W; Wakamatsu, K; Zucca, Fa; Wang, Q; Yang, K; Mohamadzadehonarvar, N; Srivastava, P; Tanaka, H; Holly, G; Casella, L; Ito, S; Zecca, L; Chen, X
Neuromelanins in brain aging and Parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative role 1-gen-2023 Zucca, Fa; Capucciati, A; Bellei, C; Sarna, M; Sarna, T; Monzani, E; Casella, L; Zecca, L
The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease 1-gen-2023 Nagatsu, T; Nakashima, A; Watanabe, H; Ito, S; Wakamatsu, K; Zucca, Fa; Zecca, L; Youdim, M; Wulf, M; Riederer, P; Dijkstra, Jm
Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders 1-gen-2022 Wise, Rm; Wagener, A; Fietzek, Um; Klopstock, T; Mosharov, Ev; Zucca, Fa; Sulzer, D; Zecca, L; Burbulla, Lf
Massive Accumulation of Sphingomyelin Affects the Lysosomal and Mitochondria Compartments and Promotes Apoptosis in Niemann-Pick Disease Type A 1-gen-2022 Carsana, Ev; Lunghi, G; Prioni, S; Mauri, L; Loberto, N; Prinetti, A; Zucca, Fa; Bassi, R; Sonnino, S; Chiricozzi, E; Duga, S; Straniero, L; Asselta, R; Soldà, G; Samarani, M; Aureli, M
Water-Soluble Melanin-Protein-Fe/Cu Conjugates Derived from Norepinephrine as Reliable Models for Neuromelanin of Human Brain Locus Coeruleus 1-gen-2022 Capucciati, A; Monzani, E; Sturini, M; Nicolis, S; Zucca, Fa; Bubacco, L; Bortolus, M; Zecca, L; Casella, L
Highly Effective Protocol for Differentiation of Induced Pluripotent Stem Cells (iPS) into Melanin-Producing Cells 1-gen-2021 Sulkowski, M; Kot, M; Badyra, B; Paluszkiewicz, A; Plonka, Pm; Sarna, M; Michalczykwetula, D; Zucca, Fa; Zecca, L; Majka, M
Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models 1-gen-2021 Capucciati, A; Zucca, Fa; Monzani, E; Zecca, L; Casella, L; Hofer, T
The neurobiology of human aggressive behavior: Neuroimaging, genetic, and neurochemical aspects 1-gen-2021 Cupaioli, Francesca A.; Zucca, Fabio A.; Caporale, Cinzia; Lesch, Klaus-Peter; Passamonti, Luca; Zecca, Luigi
Dopamine, Oxidative Stress and Protein-Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases 1-gen-2019 Monzani, E; Nicolis, S; Dell'Acqua, S; Capucciati, A; Bacchella, C; Zucca, Fa; Mosharov, Ev; Sulzer, D; Zecca, L; Casella, L
Iron, Myelin, and the Brain: Neuroimaging Meets Neurobiology 1-gen-2019 Möller, He; Bossoni, L; Connor, Jr; Crichton, Rr; Does, Md; Ward, Rj; Zecca, L; Zucca, Fa; Ronen, I
Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. 1-gen-2019 Betts, Mj; Kirilina, E; Otaduy, Mcg; Ivanov, D; Acostacabronero, J; Callaghan, Mf; Lambert, C; Cardenasblanco, A; Pine, K; Passamonti, L; Loane, C; Keuken, Mc; Trujillo, P; Lüsebrink, F; Mattern, H; Liu, Ky; Priovoulos, N; Fliessbach, K; Dahl, Mj; Maaß, A; Madelung, Cf; Meder, D; Ehrenberg, Aj; Speck, O; Weiskopf, N; Dolan, R; Inglis, B; Tosun, D; Morawski, M; Zucca, Fa; Siebner, Hr; Mather, M; Uludag, K; Heinsen, H; Poser, Ba; Howard, R; Zecca, L; Rowe, Jb; Grinberg, Lt; Jacobs, Hil; Düzel, E; Hämmerer, D
Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain 1-gen-2019 Cassidy C.M.; Zucca F.A.; Girgis R.R.; Baker S.C.; Weinstein J.J.; Sharp M.E.; Bellei C.; Valmadre A.; Vanegas N.; Kegeles L.S.; Brucato G.; Kang U.J.; Sulzer D.; Zecca L.; AbiDargham A.; Horga G.
Overexpression of Vesicular Monoamine Transporter-2 may Block Neurotoxic Metabolites from Cytosolic Dopamine: a Potential Neuroprotective Therapy for Parkinson's Disease 1-gen-2019 Seguraaguilar, J; Sulzer, D; Zucca, Fa; Zecca, L
A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrest 1-gen-2018 Samarani, M; Loberto, N; Soldà, G; Straniero, L; Asselta, R; Duga, S; Lunghi, G; Zucca, Fa; Mauri, L; Ciampa, Mg; Schiumarini, D; Bassi, R; Giussani, P; Chiricozzi, E; Prinetti, A; Aureli, M; Sonnino, S
Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease 1-gen-2018 Sulzer D.; Cassidy C.; Horga G.; Kang U.J.; Fahn S.; Casella L.; Pezzoli G.; Langley J.; Hu X.P.; Zucca F.A.; Isaias I.U.; Zecca L.
Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease 1-gen-2018 Zucca, Fa; Vanna, R; Cupaioli, Fa; Bellei, C; De Palma, A; Di Silvestre, D; Mauri, P; Grassi, S; Prinetti, A; Casella, L; Sulzer, D; Zecca, L
Contrast mechanisms associated with neuromelanin-MRI 1-gen-2017 Trujillo P.; Summers P.E.; Ferrari E.; Zucca F.A.; Sturini M.; Mainardi L.T.; Cerutti S.; Smith A.K.; Smith S.A.; Zecca L.; Costa A.